Hepacure Pharma
unknown
unknown
Stage
About
Develops novel peptide therapies targeting fatty liver disease (NAFLD) to address fat build-up in the liver.
Explore Hepacure Pharma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.